Skip to content

Author

G. Viswanatha

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

The role of thyroid hormone beta 1 receptor (THRβ1) in metabolic dysfunction associated steatohepatitis (MASH): from dysregulation to therapeutic target.

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), is still one of the most common chronic liver diseases worldwide. The build-up of triglycerides in the liver is a key feature of MASLD and can lead to oxidative stress and inflammation, there...

R. Patil, G. Viswanatha, Sai Balaji Andugulapati et al. · 0 citations
Review Aug 2026

From Peptides to Aliskiren: The Evolution of Direct Renin Inhibitors in Hypertension Therapy.

Hypertension remains a major global health concern, significantly contributing to the burden of cardiovascular, renal, and cerebrovascular diseases. Conventional pharmacological interventions include calcium channel blockers, beta-blockers, diuretics, Angiotensin-Converting Enzyme Inhibitors (ACEIs), and Angiotensin Re...

Pubali Saha, Sanyukta Bhattacharya, Tenzin Adon et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.